Which type of depot do patients prefer and has less side effects?
Research type
Research Study
Full title
Comparing patient satisfaction and tolerance in typical and atypical anti-psychotic long-acting injections.
IRAS ID
167523
Contact name
Lisa Brownell
Contact email
Duration of Study in the UK
0 years, 2 months, 9 days
Research summary
Schizophrenia is a long-term serious mental illness which lead to a variety of psychological symptoms. It effects between 5-10 people in every 1000 in the UK. It is treated with medication, known as antipsychotics, which can have many side effects. These side effects understandably impact upon quality of life in people taking these types of medications. Around twenty years ago, newer medications were developed that at the time believed to be better in treating schizophrenia, however recent research suggest the older medication may be just as good and a lot less expensive. This study wants to see which medications patients think are better and have fewer side effects. The paper will look at patients who take injected medications, as patients’ preferences of antipsychotic type has not been looked at in injected medications yet. Patients will be asked to fill out a questionnaire, which will then be used to work out if the newer and older medications are equal, or if patients are happier on newer medications.
REC name
Yorkshire & The Humber - Leeds West Research Ethics Committee
REC reference
14/YH/1296
Date of REC Opinion
9 Jan 2015
REC opinion
Further Information Favourable Opinion